These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12498778)

  • 21. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
    Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
    Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
    Chakraborty M; Sengupta A; Bhattacharya D; Banerjee S; Chakrabarti A
    Biochim Biophys Acta; 2010 Oct; 1804(10):2016-24. PubMed ID: 20637319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
    Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.
    Peretti M; Villard J; Barras E; Zufferey M; Reith W
    Mol Cell Biol; 2001 Sep; 21(17):5699-709. PubMed ID: 11486010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
    Prod'homme T; Dekel B; Barbieri G; Lisowska-Grospierre B; Katz R; Charron D; Alcaide-Loridan C; Pollack S
    Immunogenetics; 2003 Nov; 55(8):530-9. PubMed ID: 14574520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.
    Aluri J; Gupta M; Dalvi A; Mhatre S; Kulkarni M; Hule G; Desai M; Shah N; Taur P; Vedam R; Madkaikar M
    Front Immunol; 2018; 9():188. PubMed ID: 29527204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V; Otten LA; Zufferey M; Mach B
    Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman L; Peterlin BM
    Int Immunol; 2003 Apr; 15(4):467-75. PubMed ID: 12663676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The case of the bare lymphocyte syndrome--tracking down faulty transcription factors.
    Schwartz RS
    N Engl J Med; 1997 Sep; 337(11):781-3. PubMed ID: 9287236
    [No Abstract]   [Full Text] [Related]  

  • 32. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
    Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
    J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
    Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
    J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.
    Zhu XS; Linhoff MW; Li G; Chin KC; Maity SN; Ting JP
    Mol Cell Biol; 2000 Aug; 20(16):6051-61. PubMed ID: 10913187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene.
    Peijnenburg A; Van Eggermond MC; Van den Berg R; Sanal O; Vossen JM; Van den Elsen PJ
    Immunogenetics; 1999 Apr; 49(4):338-45. PubMed ID: 10079298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
    J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
    Garvie CW; Boss JM
    Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
    Mudhasani R; Fontes JD
    Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
    Brickey WJ; Wright KL; Zhu XS; Ting JP
    J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.